Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
However, the UACR reduction was not significantly different (Tuttle et al., 2018)
But alongside their rapid adoption, troubling patterns have emerged: serious gastrointestinal complications, gallbladder disease, and cases of gastroparesis that leave patients in chronic pain or require emergency surgery
AnaptysBio is developing its own wholly owned PD-1 agonist candidate for rheumatoid arthritis, rosnilimab, with data expected in Q1 2025
Seasonality of tropical airborne algae: a 16-month study based on high-throughput sequencing in the Hawaiian Islands
Purified OTUD5 was incubated with 1 g of OTUB1* [50 mM Tris-HCl (pH 7.5) and 10 mM DTT] or buffer (2 h, 37 C) in a 10 L reaction volume
